Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
Background: Many of the known coronaviruses cause a wide range of respiratory infections in humans, and the novel coronavirus is no exception to this rule. Although no drug has yet been discovered to prevent or treat this disease, chloroquine (CQ) and hydroxychloroquine (HCQ)have been widely used in...
Guardado en:
Autores principales: | Kavous Shahsavarinia, Morteza Ghojazadeh, Sarvin Sanaie, Leila Vahedi, Mahta Ahmadpour, Ata Mahmoodpoor, Hassan Soleimanpour |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Tabriz University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e03019ba87324b6ba24312606790b0cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19
por: Jarir At Thobari
Publicado: (2021) -
Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
por: Tangtavorn N, et al.
Publicado: (2016) -
Chloroquine/Hydroxychloroquine Use and Suicide Risk: Hypotheses for Confluent Etiopathogenetic Mechanisms?
por: Alessandra Costanza, et al.
Publicado: (2021) -
Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions
por: Mayra Souza Botelho, et al.
Publicado: (2021) -
Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
por: Rouamba T, et al.
Publicado: (2021)